Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

PRISMAP+ - Furthering the European Medical Radionuclide Programme

Objetivo

PRISMAP + - furthering the European Medical Radionuclide Programme, federates a consortium of 23 beneficiary or associate institutes. Nuclear medicine and research with novel radiopharmaceuticals is fast evolving with the 1st blockbuster treatment radiopharmaceutical Pluvicto® on the market last year. Based on recommendations from the Council of Europe to consolidate the European Radioisotope Valley Initiative programme and associated R&D for medical radionuclides, and therefore to extend the successful PRISMAP programme, PRISMAP + is submitted to this call to coordinate the access for biomedical researchers in Europe to a consortium of leading facilities. It extends the supply chain in geographical and scope from the maturing PRISMAP consortium, including intense neutron sources, proton and alpha accelerators, mass separation, including 2 new operating accelerators, and hosting researchers in our biomedical hubs. Planned for 2026-2029, the access platform radionuclides.eu will display relevant evolving information, manage the access in the project selection and publish relevant information as projects outcomes and dissemination become necessary. Accesses to services will furthermore be provided in our biomedical hubs, extended to larger geographical reach in Norway and Greece.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-RIA - HORIZON Research and Innovation Actions

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-INFRA-2025-01

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

ORGANISATION EUROPEENNE POUR LA RECHERCHE NUCLEAIRE
Aportación neta de la UEn
€ 1 078 968,75
Dirección
ESPLANADE DES PARTICULES 1 PARCELLE 11482 DE MEYRIN BATIMENT CADASTRAL 1046
1211 GENEVE 23
Suiza
Región
Schweiz/Suisse/Svizzera Région lémanique Genève
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 1 078 968,75

Participantes (20)

Socios (3)